Rafferty Asset Management, LLC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 1389426
New York, NY
Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,089,601
+$26,215 QoQ
Shares Held
56,157
-13.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#100
of 252 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. CLDX ranks #59 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in CLDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,089,601 | 56,157 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,063,386 | 65,050 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,102,486 | 114,230 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,521,290 | 97,460 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,456,205 | 71,558 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,966,334 | 108,338 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,852,512 | 152,454 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,092,750 | 90,990 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,422,472 | 119,494 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,033,687 | 191,415 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,870,036 | 148,009 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,535,020 | 164,790 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,972,886 | 205,508 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,243,581 | 145,736 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,388,262 | 143,331 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,838,250 | 207,693 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,337,809 | 123,806 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,321,943 | 156,252 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,568,603 | 144,115 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,085,204 | 57,144 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,625,073 | 78,501 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,493,815 | 121,059 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $451,858 | 25,791 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||